학술논문
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years -- Increasing Community Access to Testing Program, United States, July 2022--February 2023.
Document Type
Article
Author
Source
Subject
*COVID-19 vaccines
*CAREGIVERS
*DISEASES
*INFECTION
*YOUTH
*
*
*
*
Language
ISSN
0149-2195
Abstract
The article presents the discussion on interim recommendations for use of the 2-dose monovalent Moderna COVID-19 vaccine as a primary series. Topics include caregivers of minors reporting information on the presence of COVID-19–like illness symptoms, previous SARS-CoV-2 infection; and postauthorization estimates of COVID-19 VE against symptomatic infection in young children.